Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Transcriptional regulation of A33 antigen expression by gut-enriched Krüppel-like factor

Abstract

A33 antigen is a membrane-bound protein that is expressed only in intestinal epithelium and in most human colon cancers. Thus, A33 antigen has been explored as a potential therapeutic target for the treatment of colon cancers. However, little is known about the mechanism responsible for the tissue-specific pattern of its expression. In this report, we demonstrate that gut-enriched Krüppel-like factor (GKLF) binds to the promoter region of A33 antigen gene in colonic carcinoma cells and that mutations in the GKLF binding sequence in this region lead to diminished expression of A33 antigen. In addition, the expression of GKLF is linked to the expression of A33 antigen and blocking the expression of GKLF leads to the abolishment of A33 antigen expression. These results suggest that GKLF is a critical regulator in inducing the expression of A33 antigen in intestinal epithelium. While it has been suggested that GKLF is a regulator in inducing cell growth arrest and differentiation of the intestine, our observation that A33 antigen gene is a downstream target for GKLF suggests a more complex and diverse role for GKLF in the gut.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Abbreviations

GKLF:

gut-enriched Krüppel-like factor

EGFP:

enhanced green fluorescent protein

EMSA:

electrophoretic mobility shift assays

References

  • Abud HE, Johnstone CN, Tebbutt NC and Heath JK . (2000). Mech. Dev., 98, 111–114.

  • Antoniw P, Farnsworth AP, Turner A, Haines AM, Mountain A, Mackintosh J, Shochat D, Humm J, Welt S, Old LJ, Yarranton GT and King DJ . (1996). Br. J. Cancer, 74, 513–524.

  • Barendswaard EC, Humm JL, O′Donoghue JA, Sgouros G, Finn RD, Scott AM, Larson SM and Welt S . (2001). J. Nucl. Med., 42, 1251–1256.

  • Behr R and Kaestner KH . (2002). Mech. Dev., 115, 167–169.

  • Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL and Finberg RW . (1997). Science, 275, 1320–1323.

  • Bergelson JM, Krithivas A, Celi L, Droguett G, Horwitz MS, Wickham T, Crowell RL and Finberg RW . (1998). J. Virol., 72, 415–419.

  • Black AR, Black JD and Azizkhan-Clifford J . (2001). J. Cell. Physiol., 188, 143–160.

  • Brembeck FH and Rustgi AK . (2000). J. Biol. Chem., 275, 28230–28239.

  • Catimel B, Ritter G, Welt S, Old LJ, Cohen L, Nerrie MA, White SJ, Heath JK, Demediuk B, Domagala T, Lee FT, Scott AM, Tu GF, Ji H, Moritz RL, Simpson RJ, Burgess AW and Nice BC . (1996). J. Biol. Chem., 271, 25664–25670.

  • Chen ZY, Shie JL and Tseng CC . (2002). J. Biol. Chem., 277, 46831–46839.

  • Chretien I, Marcuz A, Courtet M, Katevuo K, Vainio O, Heath JK, White SJ and Du Pasquier L . (1998). Eur. J. Immunol., 28, 4094–4104.

  • Chretien I, Robert J, Marcuz A, Garcia-Sanz JA, Courtet M and Du Pasquier L . (1996). Eur. J. Immunol., 26, 780–791.

  • Foster KW, Frost AR, McKie-Bell P, Lin CY, Engler JA, Grizzle WE and Ruppert JM . (2000). Cancer Res., 60, 6488–6495.

  • Geiman DE, Ton-That H, Johnson JM and Yang VW . (2000). Nucleic Acids Res., 28, 1106–1113.

  • Gray S, Feinberg MW, Hull S, Kuo CT, Watanabe M, Sen-Banerjee S, DePina A, Haspel R and Jain MK . (2002). J. Biol. Chem., 277, 34322–34328.

  • Heath JK, White SJ, Johnstone CN, Catimel B, Simpson RJ, Moritz RL, Tu GF, Ji H, Whitehead RH, Groenen LC, Scott AM, Ritter G, Cohen L, Welt S, Old LJ, Nice EC and Burgess AW . (1997). Proc. Natl. Acad. Sci. USA, 94, 469–474.

  • Jenkins TD, Opitz OG, Okano J and Rustgi AK . (1998). J. Biol. Chem., 273, 10747–10754.

  • Johnstone CN, White SJ, Tebbutt NC, Clay FJ, Ernst M, Biggs WH, Viars CS, Czekay S, Arden KC and Heath JK . (2002). J. Biol. Chem., 277, 34531–34539.

  • Katevuo K, Imhof BA, Boyd R, Chidgey A, Bean A, Dunon D, Gobel TW and Vainio O . (1999). J. Immunol., 162, 5685–5694.

  • Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, Yang VW and Kaestner KH . (2002). Development, 129, 2619–2628.

  • King DJ, Antoniw P, Owens RJ, Adair JR, Haines AM, Farnsworth AP, Finney H, Lawson AD, Lyons A and Baker TS (1995). Br. J. Cancer, 72, 1364–1372.

  • Mahatan CS, Kaestner KH, Geiman DE and Yang VW . (1999). Nucleic Acids Res., 27, 4562–4459.

  • McCormick SM, Eskin SG, McIntire LV, Teng CL, Lu CM, Russell CG and Chittur KK . (2001). Proc. Natl. Acad. Sci. USA, 98, 8955–8960.

  • Miller KA, Eklund EA, Peddinghaus ML, Cao Z, Fernandes N, Turk PW, Thimmapaya B and Weitzman SA . (2001). J. Biol. Chem., 276, 42863–42868.

  • Nickenig G, Baudler S, Muller C, Werner C, Werner N, Welzel H, Strehlow K and Bohm M . (2002). FASEB J., 16, 1077–1086.

  • Ohnishi S, Laub F, Matsumoto N, Asaka M, Ramirez F, Yoshida T and Terada M . (2000). Dev. Dyn., 217, 421–429.

  • Okano J, Opitz OG, Nakagawa H, Jenkins TD, Friedman SL and Rustgi AK . (2000). FEBS Lett., 473, 95–100.

  • Sakamoto J, Kojima H, Kato J, Hamashima H and Suzuki H . (2000). Cancer Chemother. Pharmacol., 46(Suppl), S27–S32.

  • Shie JL, Chen ZY, Fu M, Pestell RG and Tseng CC . (2000a). Nucleic Acids Res., 28, 2969–2976.

  • Shie JL, Chen ZY, O'Brien MJ, Pestell RG, Lee ME and Tseng CC . (2000b). Am. J. Physiol. Gastrointest. Liver Physiol., 279, G806–G814.

  • Shields JM, Christy RJ and Yang VW . (1996). J. Biol. Chem., 271, 20009–20017.

  • Tomko RP, Xu R and Philipson L . (1997). Proc. Natl. Acad. Sci. USA, 94, 3352–3356.

  • Ton-That H, Kaestner KH, Shields JM, Mahatanankoon CS and Yang VW . (1997). FEBS Lett., 419, 239–243.

  • Welt S, Divgi CR, Kemeny N, Finn RD, Scott AM, Graham M, Germain JS, Richards EC, Larson SM and Oettgen HF (1994). J. Clin. Oncol., 12, 1561–1571.

  • Welt S, Scott AM, Divgi CR, Kemeny NE, Finn RD, Daghighian F, Germain JS, Richards EC, Larson SM and Old LJ . (1996). J. Clin. Oncol., 14, 1787–1797.

  • Yet SF, McA'Nulty MM, Folta SC, Yen HW, Yoshizumi M, Hsieh CM, Layne MD, Chin MT, Wang H, Perrella MA, Jain MK and Lee ME . (1998). J. Biol. Chem., 273, 1026–1031.

  • Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, Biggs JR, Kraft AS and Yang VW . (2000). J. Biol. Chem., 275, 18391–18398.

  • Zhang W, Shields JM, Sogawa K, Fujii-Kuriyama Y and Yang VW . (1998). J. Biol. Chem., 273, 17917–17925.

Download references

Acknowledgements

This work was supported by grants (30000199 to ZM and 30225043 to YS) from National Natural Science Foundation of China.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yongfeng Shang or Tanjun Tong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mao, Z., Shan, S., Zhu, Y. et al. Transcriptional regulation of A33 antigen expression by gut-enriched Krüppel-like factor. Oncogene 22, 4434–4443 (2003). https://doi.org/10.1038/sj.onc.1206508

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206508

Keywords

This article is cited by

Search

Quick links